About the company

Czech quality, tradition and innovation

The name CZECH-GEN embodies three key pillars of our identity. The first is representing high-quality Czech craftsmanship worldwide. The second is our tradition across generations: our company has operated successfully in the market for three decades. The third is our portfolio, focused on developing and manufacturing active ingredients for generic medicines. By combining tradition, experience and innovation, we create the very heart of medicines that help patients in nearly one hundred countries around the world.

90

%

Production exported

80

+

Countries worldwide

270

+

Specialists

34

years of experience

[Certification]

CEP

EU GMP

US FDA

ASMF

US DMF

ISO 2020

[EXPORT]

European Union

United States

Japan

India

China

history

Our company history

The industrial tradition of the site where our company operates dates back to the 19th century, starting with the production of malt and salt. A fundamental transformation of this location into a chemical enterprise and the initial production of pharmaceuticals was then realized by the owners in the 1930s. The post-war period launched the large-scale manufacturing of active pharmaceutical ingredients through chemical synthesis. In the 1950s, this operation was taken over by the newly renamed state-owned enterprise Farmakon n. p., renowned for its massive production of B and C vitamins.

In the 1990s, the company transformed into a private, family-owned business and successfully expanded worldwide under the name Farmak. After 1996, the achievements of our Research and Development department were heavily utilized, expanding the product portfolio with new substances such as tizanidine, brimonidine, alfuzosin, tamsulosin, zolpidem, zopiclone, and others. These were high-value-added products with significantly lower demands on equipment capacity and ecological waste disposal. In response to new market challenges and after three decades of building a successful business, we have adopted the new brand name CZECH-GEN. With this step, we confirm the continuity of our family generations and the quality of Czech craftsmanship.

Ing. Jiří Žák, zakladatel Czech-Gen Group

1934

The start of industrial chemical production; the construction of a modern six-storey building.

1952

The company became independent and was renamed Farmakon, n. p., and the plant in Uničov, which manufactures veterinary medicines, biofactor supplements and feed preparations, was incorporated into the company.

1992

The inaugural general meeting of FARMAK, a.s.

1996

Takeover of the state-owned enterprise Farmakon n. p. and commencement of restructuring.

1996

Expansion of the product range to include new substances, thanks to the application of the research and development department’s findings.

1997

Flooding: there was over 2 metres of water on the company’s premises, and production was halted for three months.

1998

The first inspection by the US FDA (Food and Drug Administration) for the registration of medicinal substances in the US.

2004

A new production unit was built in Building No. 33 – the Unihala, comprising quality control (QC) laboratories and a new quality assurance (QA) department, as well as research and development laboratories, including the necessary instrumentation. Named ‘Building of the Year’ in the Olomouc Region in 2004.

2008

Installation of the new Kilolab in accordance with cGMP.

2014

Construction of a new final assembly hall.

2018

Refurbishment of the hydrogenation unit in Building No. 21.

2019

Construction of the new SAU 13.02 production unit in Building No. 13 for the manufacture of products resulting from the company’s own research and development.

2023

Refurbishment of production unit PJ 20.06 in building no. 33

2026

The company’s rebranding and the adoption of the new name CZECH-GEN, a.s.

Ing. Jiří Žák, zakladatel Czech-Gen Group

Ing. Jiří Žák

Founder · Chairman of the Supervisory Board of CZECH-GEN

Origins and continuity

founder

The founder of the company is Jiří Žák, a prominent Czech entrepreneur, visionary, and chemical expert who has dedicated almost his entire professional career to the company. After completing his studies, he joined the state-owned enterprise Farmakon. Shortly after the Velvet Revolution, he became the director of the company, and during privatization, he and his colleagues acquired it with the help of a bank loan and renamed it FARMAK. However, the following year, a flood devastated the company premises, and fearing the repayment of the loan, most of his partners sold him their shares. Jiří Žák did not give up and subsequently led the company to remarkable success, building a strong position in international markets, especially in the USA. In 2026, the company adopted the new name CZECH-GEN. His successes have earned Jiří Žák several prestigious awards, including the title of Entrepreneur of the Year of the Olomouc Region and the esteemed Gentleman Pro title in the Czech 100 Best competition.

By progressively expanding his business portfolio, Jiří Žák built a strong holding group that now successfully develops activities across diverse market segments in the Czech Republic and internationally. CZECH-GEN GROUP comprises four specialised companies operating in the chemical and pharmaceutical industry, cosmetics, residential development and gastronomy. We also specialise in veterinary products and medical devices. All the companies share a commitment to exceptional customer service and to fulfilling our central mission: actively contributing to better human health and quality of life.

We specialize in the custom development and manufacturing of cosmetics, dietary supplements, medical devices, and veterinary pharmaceuticals.

Learn more

Through our development company, we are preparing the construction of residential projects for the regional real estate market.

We provide canteen catering for employees working in industry and commerce. We cook authentic Czech and international cuisine using ingredients that are fresh every day.

Learn more

Our team

Board of Directors

Ing. Miroslav Ulrich

/ Chairman of the Board

Miroslav Ulrich

Ing. Miroslav Ulrich

/ Board Member

Roman Buchtík

Ing. Miroslav Ulrich

/ Board Member

Drahomír Procházka

Supervisory Board

No items found.

Management

Ing. Miroslav Ulrich

/ Chief Executive Officer

Miroslav Ulrich

Ing. Miroslav Ulrich

/ Director of R&D and Sales

Roman Buchtík

Ing. Miroslav Ulrich

/ PR Manager

Bronislava Paučková

Ing. Miroslav Ulrich

/ Quality Director

Milan Hodes

Ing. Miroslav Ulrich

/ Director of Services

David Novák

Ing. Miroslav Ulrich

/ Production Director and Chief Technologist

Jerguš Koplík

Ing. Miroslav Ulrich

/ HR manažerka

Renáta Švestková

Ing. Miroslav Ulrich

/ Head of Marketing and Spokesperson

Petr Hlávka

Global reach

Across more than
80 countries worldwide

We export more than 90% of our production. We maintain long-term partnerships in the European Union, the United States and Japan, as well as in the rapidly growing markets of Asia and Latin America.

European Union

United States

Japan

India

China

Latin America

Start a business partnership

Looking for a partner for development and manufacturing?

Contact us to discuss active pharmaceutical ingredients, CDMO services or specialty chemicals.

Discuss a partnership